Axin1 binds to YAP/TAZ to regulate YAP/TAZ stability; activation of Hippo via overexpression of Lats2 or deletion of YAP/TAZ significantly inhibits c-Met/sgAxin1-driven HCC development. The gene discussed is MET; the disease is hepatocellular carcinoma.